The SIRT1 activator resveratrol has been demonstrated to attenuate diabetes development in NOD mice (82), and familial mutations in SIRT1 are associated with an increased risk for T1D development in humans (83). Here, SIRT1 is linked to type 1 diabetes mellitus.